Local Institution

Madison, Wisconsin 53792

0 studies enrolling now · 9 studies all time

What they study most

Congestive Heart Failure, Coronary Artery Disease, Diabetes Mellitus II, HIV Infections, Hypertension, Multiple Sclerosis, Non-Small-Cell Lung Carcinoma, Rheumatoid Arthritis

Studies at this site

• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress. — Stopped early
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis — Stopped early
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed